{"slug":"vip-plantar-fasciitis","verification":{"valid":true,"entries":3,"head":"e68986c867320341cddfb90eb0fd7969a11ce3fa1ca983832dafe1849f045ed5"},"count":3,"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","summary":"Review on VIP in inflammatory diseases.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","summary":"Summary of mouse CIA model results.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"timeout","quote_status":"unverified","prev":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe","hash":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","summary":"Human study on VIP levels and RA outcomes.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"timeout","quote_status":"unverified","prev":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b","hash":"e68986c867320341cddfb90eb0fd7969a11ce3fa1ca983832dafe1849f045ed5"}]}